Review



pc3 androgen independent  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC pc3 androgen independent
    Pc3 Androgen Independent, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 14343 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pc3 androgen independent/product/ATCC
    Average 99 stars, based on 14343 article reviews
    pc3 androgen independent - by Bioz Stars, 2026-06
    99/100 stars

    Images



    Similar Products

    99
    ATCC pc3 androgen independent
    Pc3 Androgen Independent, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pc3 androgen independent/product/ATCC
    Average 99 stars, based on 1 article reviews
    pc3 androgen independent - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC androgen independent prostate carcinoma du 145 cell line
    Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from PC-3, LNCaP and <t>DU</t> <t>145</t> cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).
    Androgen Independent Prostate Carcinoma Du 145 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/androgen independent prostate carcinoma du 145 cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    androgen independent prostate carcinoma du 145 cell line - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC androgen independent prostate carcinoma du 145 cell line 249
    Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from PC-3, LNCaP and <t>DU</t> <t>145</t> cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).
    Androgen Independent Prostate Carcinoma Du 145 Cell Line 249, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/androgen independent prostate carcinoma du 145 cell line 249/product/ATCC
    Average 99 stars, based on 1 article reviews
    androgen independent prostate carcinoma du 145 cell line 249 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC androgen independent prostate carcinoma pc 3 cell line
    Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from <t>PC-3,</t> LNCaP and DU 145 cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).
    Androgen Independent Prostate Carcinoma Pc 3 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/androgen independent prostate carcinoma pc 3 cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    androgen independent prostate carcinoma pc 3 cell line - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC androgen independent 248 prostate carcinoma pc 3 cell line
    Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from <t>PC-3,</t> LNCaP and DU 145 cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).
    Androgen Independent 248 Prostate Carcinoma Pc 3 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/androgen independent 248 prostate carcinoma pc 3 cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    androgen independent 248 prostate carcinoma pc 3 cell line - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC androgen independent
    Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from <t>PC-3,</t> LNCaP and DU 145 cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).
    Androgen Independent, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/androgen independent/product/ATCC
    Average 99 stars, based on 1 article reviews
    androgen independent - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC androgen independent prostate cancer cell line pc 3
    Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from <t>PC-3,</t> LNCaP and DU 145 cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).
    Androgen Independent Prostate Cancer Cell Line Pc 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/androgen independent prostate cancer cell line pc 3/product/ATCC
    Average 99 stars, based on 1 article reviews
    androgen independent prostate cancer cell line pc 3 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC human androgen receptor independent prostate cancer aripc cell lines du145
    Depletion of ACACA promotes inflammation in ARIPC cells. ( A-B ) Inflammatory pathways significantly enriched in ACACA-depleted ARIPC cells. ( C-D ) GSEA showed that the ‘Regulation of inflammatory response’ was activated in ACACA-depleted ARIPC cells on the basis of the transcriptome data. ( E-F ) Heatmap of inflammatory biomarker-related gene expression in ACACA-depleted ARIPC cells on the basis of transcriptome data. ( G ) Quantification of the qPCR analysis results of inflammation biomarker-related gene expression in ACACA depleted <t>DU145</t> cells. ( H ) Quantification of qPCR analysis results of inflammation biomarker-related gene expression in DU145 cells after TOFA treatment (10 µg/mL, 72 h). Data are represented as mean ± SD in ( G and H ). * P < 0.05
    Human Androgen Receptor Independent Prostate Cancer Aripc Cell Lines Du145, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human androgen receptor independent prostate cancer aripc cell lines du145/product/ATCC
    Average 99 stars, based on 1 article reviews
    human androgen receptor independent prostate cancer aripc cell lines du145 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC human androgen independent prostate carcinoma pc 3
    Depletion of ACACA promotes inflammation in ARIPC cells. ( A-B ) Inflammatory pathways significantly enriched in ACACA-depleted ARIPC cells. ( C-D ) GSEA showed that the ‘Regulation of inflammatory response’ was activated in ACACA-depleted ARIPC cells on the basis of the transcriptome data. ( E-F ) Heatmap of inflammatory biomarker-related gene expression in ACACA-depleted ARIPC cells on the basis of transcriptome data. ( G ) Quantification of the qPCR analysis results of inflammation biomarker-related gene expression in ACACA depleted <t>DU145</t> cells. ( H ) Quantification of qPCR analysis results of inflammation biomarker-related gene expression in DU145 cells after TOFA treatment (10 µg/mL, 72 h). Data are represented as mean ± SD in ( G and H ). * P < 0.05
    Human Androgen Independent Prostate Carcinoma Pc 3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human androgen independent prostate carcinoma pc 3/product/ATCC
    Average 99 stars, based on 1 article reviews
    human androgen independent prostate carcinoma pc 3 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    ATCC androgen independent prostate cancer cell line pc3
    A Schematic of the Tet-on LSH-shRNA system for regulating LSH expression in <t>PC3</t> cells. Treatment with doxycycline for five days (DOX_5d) resulted in a significant reduction in LSH expression compared to cells that did not receive doxycycline treatment (DOX_0d). Following a five-day washout period, LSH expression was fully rescued to normal level (RESC). B Doxycycline- inducible knockdown of LSH was assessed using Western blotting to track alterations in protein levels, with endogenous β-ACTIN serving as the loading control. C-D Representative images and the percentage of cells with micronuclei ( C ) or DNA bridge ( D ) in Tet-on LSH-shRNA PC3 cells treated as described in panel A. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. E Representative images of γ-H2AX immunostaining and bar graph show the percentage of PC3 cells containing more than five γ-H2AX foci, treated as described in panel A. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. F Representative images of the alkaline comet assay and quantification of tail moment in PC3 cells, treated as described in panel A. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. G Representative images of Edu staining and quantification of nuclear Edu signal intensity in PC3 cells, treated as described in panel A. The scale bar represents 10 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. AU denotes arbitrary units. H-I Quantification of replication fork velocity ( H ) and fork asymmetry ( I ) is presented using Tukey-style box plots. Schematic diagram of the DNA fiber assay and representative images of stretched DNA fibers in PC3 cells treated as described in panel A. Cells were sequentially labeled at the indicated time points with two different thymidine analogues— CldU (red) and IdU (green). The scale bar represents 10 μm. The central line of a Tukey-style box plot indicates the median value, while the boxes and whiskers represent the 25th to 75th percentiles and the 5th to 95th percentiles, respectively. Outliers are displayed as individual points. Data are representative of n = 4 biologically independent experiments. ***p < 0.001; n.s. indicates not significant, as determined by the One-way ANOVA with Tukey’s multiple comparison test. J Scatter plots depicting the distances covered by right-moving and left-moving bi-directional replication forks following the CldU pulse in PC3 cells treated as described in panel H. The central areas, delineated by red lines, represent bi-directional forks with a length difference of less than 25%. The percentage of symmetric forks is also indicated. Data are representative of n = 4 biologically independent experiments. Source data are provided as a Source Data file.
    Androgen Independent Prostate Cancer Cell Line Pc3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/androgen independent prostate cancer cell line pc3/product/ATCC
    Average 99 stars, based on 1 article reviews
    androgen independent prostate cancer cell line pc3 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    Image Search Results


    Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from PC-3, LNCaP and DU 145 cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).

    Journal: Scientific Reports

    Article Title: Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer

    doi: 10.1038/s41598-025-31838-w

    Figure Lengend Snippet: Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from PC-3, LNCaP and DU 145 cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).

    Article Snippet: The androgen-dependent LNCaP metastatic prostate carcinoma cell line (CRL-1740), androgen-independent prostate carcinoma PC-3 cell line (CRL-1435) and androgen-independent prostate carcinoma DU 145 cell line (HTB-81) were purchased from the American Type Culture Collection (ATCC).

    Techniques: Derivative Assay, Western Blot, Electron Microscopy, Concentration Assay, Software, Marker

    Effect of PC-3 and LNCaP EVs on monocyte populations. PBMCs were treated with PC-3 EVs, LNCaP EVs, DU 145 EVs and t-NEPC LNCaP EVs for 24 h. a ) Comparison of % CD14 + CD16 + rare monocytes from 10 healthy volunteers treated with EVs derived from PC-3, LNCaP and DU 145. b ) Comparison of % CD14 + CD16 + rare monocytes treated with EVs derived from PC-3, LNCaP and DU 145 in respect to the untreated samples (CTRL). c ) Comparison of % CD14 + CD16 + rare monocytes treated with EVs derived from PC-3 compared to t-NEPC LNCaP treated cells. Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; **** p < 0.0001; *** indicates p < 0.001; n.s. = not significant.

    Journal: Scientific Reports

    Article Title: Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer

    doi: 10.1038/s41598-025-31838-w

    Figure Lengend Snippet: Effect of PC-3 and LNCaP EVs on monocyte populations. PBMCs were treated with PC-3 EVs, LNCaP EVs, DU 145 EVs and t-NEPC LNCaP EVs for 24 h. a ) Comparison of % CD14 + CD16 + rare monocytes from 10 healthy volunteers treated with EVs derived from PC-3, LNCaP and DU 145. b ) Comparison of % CD14 + CD16 + rare monocytes treated with EVs derived from PC-3, LNCaP and DU 145 in respect to the untreated samples (CTRL). c ) Comparison of % CD14 + CD16 + rare monocytes treated with EVs derived from PC-3 compared to t-NEPC LNCaP treated cells. Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; **** p < 0.0001; *** indicates p < 0.001; n.s. = not significant.

    Article Snippet: The androgen-dependent LNCaP metastatic prostate carcinoma cell line (CRL-1740), androgen-independent prostate carcinoma PC-3 cell line (CRL-1435) and androgen-independent prostate carcinoma DU 145 cell line (HTB-81) were purchased from the American Type Culture Collection (ATCC).

    Techniques: Comparison, Derivative Assay

    PC-3-EVs effects on innate lymphoid and NK cells compared to LNCaP-EVs. Effect of prostate cancer EVs on innate immune cells. a ) The percentage of CD4 + HLA-DR + after treatment with EVs derived from PC-3 and DU 145 compared to LNCaP treatment. b ) The percentage of CD8 + HLA-DR + treated with EVs derived from PC-3 and DU 145 in comparison to LNCaP treatment. c ) Comparison of the ratio of CD4 + HLA-DR + regarding the CD4 + . d ) Comparison of ratio of CD8 + HLA-DR + in regard to the CD8 + . Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; * indicates p < 0.05; n.s. = not significant.

    Journal: Scientific Reports

    Article Title: Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer

    doi: 10.1038/s41598-025-31838-w

    Figure Lengend Snippet: PC-3-EVs effects on innate lymphoid and NK cells compared to LNCaP-EVs. Effect of prostate cancer EVs on innate immune cells. a ) The percentage of CD4 + HLA-DR + after treatment with EVs derived from PC-3 and DU 145 compared to LNCaP treatment. b ) The percentage of CD8 + HLA-DR + treated with EVs derived from PC-3 and DU 145 in comparison to LNCaP treatment. c ) Comparison of the ratio of CD4 + HLA-DR + regarding the CD4 + . d ) Comparison of ratio of CD8 + HLA-DR + in regard to the CD8 + . Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; * indicates p < 0.05; n.s. = not significant.

    Article Snippet: The androgen-dependent LNCaP metastatic prostate carcinoma cell line (CRL-1740), androgen-independent prostate carcinoma PC-3 cell line (CRL-1435) and androgen-independent prostate carcinoma DU 145 cell line (HTB-81) were purchased from the American Type Culture Collection (ATCC).

    Techniques: Derivative Assay, Comparison

    Release of cytokines by immune cells after treatment with prostate cancer EVs. Seven pro- and anti-inflammatory cytokines were evaluated from the conditioned medium of PBMCs from 10 healthy donors and samples treated with PC-3-EVs, LNCaP-EVs and DU 145 EVs for 24h. a ) Level of IL-6 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. b ) Level of MIP-1α between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. c ) Level of IL-7 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. d ) Level of IFN-α2 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. e ) Level of IL-10 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. f ) Level of MCP-1 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. g ) Level of G-CSF between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; **** indicates p < 0.0001; ***indicates p < 0.001; ** indicates p < 0.01; *indicates p < 0.05.

    Journal: Scientific Reports

    Article Title: Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer

    doi: 10.1038/s41598-025-31838-w

    Figure Lengend Snippet: Release of cytokines by immune cells after treatment with prostate cancer EVs. Seven pro- and anti-inflammatory cytokines were evaluated from the conditioned medium of PBMCs from 10 healthy donors and samples treated with PC-3-EVs, LNCaP-EVs and DU 145 EVs for 24h. a ) Level of IL-6 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. b ) Level of MIP-1α between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. c ) Level of IL-7 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. d ) Level of IFN-α2 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. e ) Level of IL-10 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. f ) Level of MCP-1 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. g ) Level of G-CSF between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; **** indicates p < 0.0001; ***indicates p < 0.001; ** indicates p < 0.01; *indicates p < 0.05.

    Article Snippet: The androgen-dependent LNCaP metastatic prostate carcinoma cell line (CRL-1740), androgen-independent prostate carcinoma PC-3 cell line (CRL-1435) and androgen-independent prostate carcinoma DU 145 cell line (HTB-81) were purchased from the American Type Culture Collection (ATCC).

    Techniques:

    Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from PC-3, LNCaP and DU 145 cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).

    Journal: Scientific Reports

    Article Title: Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer

    doi: 10.1038/s41598-025-31838-w

    Figure Lengend Snippet: Characterisation of prostate cancer-derived extracellular vesicles. EVs post differential ultracentrifugation were characterised using nanoparticle tracking analysis (NTA), immunoblotting analysis, and scanning electron microscopy (SEM). a ). Particle concentration and size of which three replicates of each sample were analysed by NTA independently. Data analysed by one-way ANOVA test and presented as mean bars (n = 3) ± SEM, the significant p-value is reported; * indicates p < 0.05, ** indicates p < 0.01. n.s. = not significant. b ) Representative graphs of prostate cancer EVs distribution from NTA software. c )Immunoblotting analysis of EVs from PC-3, LNCaP and DU 145 cells and cell lysates. Detection of EVs associated positive markers, syntenin, CD63, and negative marker calnexin. SEM images of d ) PC-3 EVs, e ) LNCaP EVs and f) DU 145 EVs with a range of 90 nm to 130 nm (magnification 62000x).

    Article Snippet: The androgen-dependent LNCaP metastatic prostate carcinoma cell line (CRL-1740), androgen-independent prostate carcinoma PC-3 cell line (CRL-1435) and androgen-independent prostate carcinoma DU 145 cell line (HTB-81) were purchased from the American Type Culture Collection (ATCC).

    Techniques: Derivative Assay, Western Blot, Electron Microscopy, Concentration Assay, Software, Marker

    Effect of PC-3 and LNCaP EVs on monocyte populations. PBMCs were treated with PC-3 EVs, LNCaP EVs, DU 145 EVs and t-NEPC LNCaP EVs for 24 h. a ) Comparison of % CD14 + CD16 + rare monocytes from 10 healthy volunteers treated with EVs derived from PC-3, LNCaP and DU 145. b ) Comparison of % CD14 + CD16 + rare monocytes treated with EVs derived from PC-3, LNCaP and DU 145 in respect to the untreated samples (CTRL). c ) Comparison of % CD14 + CD16 + rare monocytes treated with EVs derived from PC-3 compared to t-NEPC LNCaP treated cells. Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; **** p < 0.0001; *** indicates p < 0.001; n.s. = not significant.

    Journal: Scientific Reports

    Article Title: Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer

    doi: 10.1038/s41598-025-31838-w

    Figure Lengend Snippet: Effect of PC-3 and LNCaP EVs on monocyte populations. PBMCs were treated with PC-3 EVs, LNCaP EVs, DU 145 EVs and t-NEPC LNCaP EVs for 24 h. a ) Comparison of % CD14 + CD16 + rare monocytes from 10 healthy volunteers treated with EVs derived from PC-3, LNCaP and DU 145. b ) Comparison of % CD14 + CD16 + rare monocytes treated with EVs derived from PC-3, LNCaP and DU 145 in respect to the untreated samples (CTRL). c ) Comparison of % CD14 + CD16 + rare monocytes treated with EVs derived from PC-3 compared to t-NEPC LNCaP treated cells. Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; **** p < 0.0001; *** indicates p < 0.001; n.s. = not significant.

    Article Snippet: The androgen-dependent LNCaP metastatic prostate carcinoma cell line (CRL-1740), androgen-independent prostate carcinoma PC-3 cell line (CRL-1435) and androgen-independent prostate carcinoma DU 145 cell line (HTB-81) were purchased from the American Type Culture Collection (ATCC).

    Techniques: Comparison, Derivative Assay

    PC-3-EVs effects on innate lymphoid and NK cells compared to LNCaP-EVs. Effect of prostate cancer EVs on innate immune cells. a ) The percentage of CD4 + HLA-DR + after treatment with EVs derived from PC-3 and DU 145 compared to LNCaP treatment. b ) The percentage of CD8 + HLA-DR + treated with EVs derived from PC-3 and DU 145 in comparison to LNCaP treatment. c ) Comparison of the ratio of CD4 + HLA-DR + regarding the CD4 + . d ) Comparison of ratio of CD8 + HLA-DR + in regard to the CD8 + . Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; * indicates p < 0.05; n.s. = not significant.

    Journal: Scientific Reports

    Article Title: Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer

    doi: 10.1038/s41598-025-31838-w

    Figure Lengend Snippet: PC-3-EVs effects on innate lymphoid and NK cells compared to LNCaP-EVs. Effect of prostate cancer EVs on innate immune cells. a ) The percentage of CD4 + HLA-DR + after treatment with EVs derived from PC-3 and DU 145 compared to LNCaP treatment. b ) The percentage of CD8 + HLA-DR + treated with EVs derived from PC-3 and DU 145 in comparison to LNCaP treatment. c ) Comparison of the ratio of CD4 + HLA-DR + regarding the CD4 + . d ) Comparison of ratio of CD8 + HLA-DR + in regard to the CD8 + . Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; * indicates p < 0.05; n.s. = not significant.

    Article Snippet: The androgen-dependent LNCaP metastatic prostate carcinoma cell line (CRL-1740), androgen-independent prostate carcinoma PC-3 cell line (CRL-1435) and androgen-independent prostate carcinoma DU 145 cell line (HTB-81) were purchased from the American Type Culture Collection (ATCC).

    Techniques: Derivative Assay, Comparison

    T-NEPC LNCaP EVs effects on innate lymphoid and NK cells. Effect of t-NEPC LNCaP EVs on innate immune cells. a ) The percentage of CD4 + HLA-DR + after treatment with EVs derived from PC-3 compared to t-NEPC LNCaP treatment. b ) The percentage of CD8 + HLA-DR + treated with EVs derived from PC-3 compared to t-NEPC LNCaP treatment. c ) Comparison of the ratio of CD4 + HLA-DR + regarding the CD4 + . d ) Comparison of ratio of CD8 + HLA-DR + in regard to the CD8 + . Data analysed by parametric t-test and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; * indicates p < 0.05; n.s. = not significant.

    Journal: Scientific Reports

    Article Title: Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer

    doi: 10.1038/s41598-025-31838-w

    Figure Lengend Snippet: T-NEPC LNCaP EVs effects on innate lymphoid and NK cells. Effect of t-NEPC LNCaP EVs on innate immune cells. a ) The percentage of CD4 + HLA-DR + after treatment with EVs derived from PC-3 compared to t-NEPC LNCaP treatment. b ) The percentage of CD8 + HLA-DR + treated with EVs derived from PC-3 compared to t-NEPC LNCaP treatment. c ) Comparison of the ratio of CD4 + HLA-DR + regarding the CD4 + . d ) Comparison of ratio of CD8 + HLA-DR + in regard to the CD8 + . Data analysed by parametric t-test and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; * indicates p < 0.05; n.s. = not significant.

    Article Snippet: The androgen-dependent LNCaP metastatic prostate carcinoma cell line (CRL-1740), androgen-independent prostate carcinoma PC-3 cell line (CRL-1435) and androgen-independent prostate carcinoma DU 145 cell line (HTB-81) were purchased from the American Type Culture Collection (ATCC).

    Techniques: Derivative Assay, Comparison

    Release of cytokines by immune cells after treatment with prostate cancer EVs. Seven pro- and anti-inflammatory cytokines were evaluated from the conditioned medium of PBMCs from 10 healthy donors and samples treated with PC-3-EVs, LNCaP-EVs and DU 145 EVs for 24h. a ) Level of IL-6 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. b ) Level of MIP-1α between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. c ) Level of IL-7 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. d ) Level of IFN-α2 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. e ) Level of IL-10 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. f ) Level of MCP-1 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. g ) Level of G-CSF between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; **** indicates p < 0.0001; ***indicates p < 0.001; ** indicates p < 0.01; *indicates p < 0.05.

    Journal: Scientific Reports

    Article Title: Immune profiling identifies the contribution of extracellular vesicles to immune modulation and progression in prostate cancer

    doi: 10.1038/s41598-025-31838-w

    Figure Lengend Snippet: Release of cytokines by immune cells after treatment with prostate cancer EVs. Seven pro- and anti-inflammatory cytokines were evaluated from the conditioned medium of PBMCs from 10 healthy donors and samples treated with PC-3-EVs, LNCaP-EVs and DU 145 EVs for 24h. a ) Level of IL-6 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. b ) Level of MIP-1α between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. c ) Level of IL-7 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. d ) Level of IFN-α2 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. e ) Level of IL-10 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. f ) Level of MCP-1 between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. g ) Level of G-CSF between PBMCs treated with PC-3 EVs and DU 145 EVs compared to LNCaP EVs. Data analysed by one-way ANOVA and presented as mean bars (n = 10) ± SEM, the significant p -value is reported; **** indicates p < 0.0001; ***indicates p < 0.001; ** indicates p < 0.01; *indicates p < 0.05.

    Article Snippet: The androgen-dependent LNCaP metastatic prostate carcinoma cell line (CRL-1740), androgen-independent prostate carcinoma PC-3 cell line (CRL-1435) and androgen-independent prostate carcinoma DU 145 cell line (HTB-81) were purchased from the American Type Culture Collection (ATCC).

    Techniques:

    Depletion of ACACA promotes inflammation in ARIPC cells. ( A-B ) Inflammatory pathways significantly enriched in ACACA-depleted ARIPC cells. ( C-D ) GSEA showed that the ‘Regulation of inflammatory response’ was activated in ACACA-depleted ARIPC cells on the basis of the transcriptome data. ( E-F ) Heatmap of inflammatory biomarker-related gene expression in ACACA-depleted ARIPC cells on the basis of transcriptome data. ( G ) Quantification of the qPCR analysis results of inflammation biomarker-related gene expression in ACACA depleted DU145 cells. ( H ) Quantification of qPCR analysis results of inflammation biomarker-related gene expression in DU145 cells after TOFA treatment (10 µg/mL, 72 h). Data are represented as mean ± SD in ( G and H ). * P < 0.05

    Journal: Cell Communication and Signaling : CCS

    Article Title: ACACA depletion activates the cPLA2–arachidonic acid–NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer

    doi: 10.1186/s12964-025-02363-0

    Figure Lengend Snippet: Depletion of ACACA promotes inflammation in ARIPC cells. ( A-B ) Inflammatory pathways significantly enriched in ACACA-depleted ARIPC cells. ( C-D ) GSEA showed that the ‘Regulation of inflammatory response’ was activated in ACACA-depleted ARIPC cells on the basis of the transcriptome data. ( E-F ) Heatmap of inflammatory biomarker-related gene expression in ACACA-depleted ARIPC cells on the basis of transcriptome data. ( G ) Quantification of the qPCR analysis results of inflammation biomarker-related gene expression in ACACA depleted DU145 cells. ( H ) Quantification of qPCR analysis results of inflammation biomarker-related gene expression in DU145 cells after TOFA treatment (10 µg/mL, 72 h). Data are represented as mean ± SD in ( G and H ). * P < 0.05

    Article Snippet: The human androgen receptor-independent prostate cancer (ARIPC) cell lines DU145 and PC3, the androgen receptor positive prostate cancer cell line LNCaP, the benign prostatic hyperplasia cell line BPH1, and HEK293T cells were obtained from the American Type Culture Collection (ATCC, Manassas, USA).

    Techniques: Biomarker Discovery, Gene Expression

    ACACA depletion activates NF-κB signaling in ARIPC cells. ( A ) Western blot analysis of key proteins of the NF-κB signaling pathway and inflammatory signaling in ACACA-depleted DU145 cells. ( B-C ) Western blot analysis of P65 and pP65 after treatment with TOFA for 72 h at the indicated concentrations (µg/mL) in the indicated ARIPC cells. ( D ) and ( E ) Western blot analysis of P65 and pP65 expression following ACACA silencing in the indicated ARIPC cells. ( F-I ) Immunofluorescence analysis of P65 in ACACA-depleted DU145 cells generated with different shRNA sequences (shACACA#1 and shACACA#2), with the quantification presented in ( G ) and ( I ), respectively. ( J-K ) Immunofluorescence analysis of P65 in DU145 cells after TOFA treatment (72 h), with quantification presented in ( K ). ( L ) Western blot analysis of P65 and pP65 and ( M ) qPCR analysis of P65 after arachidonic acid (AA) treatment (50 µM, 72 h). ( N ) Western blot analysis of P65 and pP65 and ( M ) qPCR analysis of P65 after cPLA2 silencing in ACACA-depleted DU145 cells. ( O ) qPCR analysis of P65. Data are presented as the means ± SD in ( G, I, K, M, O ). * P < 0.05

    Journal: Cell Communication and Signaling : CCS

    Article Title: ACACA depletion activates the cPLA2–arachidonic acid–NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer

    doi: 10.1186/s12964-025-02363-0

    Figure Lengend Snippet: ACACA depletion activates NF-κB signaling in ARIPC cells. ( A ) Western blot analysis of key proteins of the NF-κB signaling pathway and inflammatory signaling in ACACA-depleted DU145 cells. ( B-C ) Western blot analysis of P65 and pP65 after treatment with TOFA for 72 h at the indicated concentrations (µg/mL) in the indicated ARIPC cells. ( D ) and ( E ) Western blot analysis of P65 and pP65 expression following ACACA silencing in the indicated ARIPC cells. ( F-I ) Immunofluorescence analysis of P65 in ACACA-depleted DU145 cells generated with different shRNA sequences (shACACA#1 and shACACA#2), with the quantification presented in ( G ) and ( I ), respectively. ( J-K ) Immunofluorescence analysis of P65 in DU145 cells after TOFA treatment (72 h), with quantification presented in ( K ). ( L ) Western blot analysis of P65 and pP65 and ( M ) qPCR analysis of P65 after arachidonic acid (AA) treatment (50 µM, 72 h). ( N ) Western blot analysis of P65 and pP65 and ( M ) qPCR analysis of P65 after cPLA2 silencing in ACACA-depleted DU145 cells. ( O ) qPCR analysis of P65. Data are presented as the means ± SD in ( G, I, K, M, O ). * P < 0.05

    Article Snippet: The human androgen receptor-independent prostate cancer (ARIPC) cell lines DU145 and PC3, the androgen receptor positive prostate cancer cell line LNCaP, the benign prostatic hyperplasia cell line BPH1, and HEK293T cells were obtained from the American Type Culture Collection (ATCC, Manassas, USA).

    Techniques: Western Blot, Expressing, Immunofluorescence, Generated, shRNA

    Depletion of ACACA causes increased arachidonic acid activity in prostate cancer cells. ( A ) Levels of two metabolites associated with arachidonic acid from metabolomic analysis data after ACACA knockdown in DU145 cells. ( B-M ) Heatmap and individual panels of arachidonic acid and its metabolite levels in ACACA-depleted PC3 cells. ( N-O ) Heatmaps showing the transcriptional expression levels of arachidonic acid pathway metabolic enzymes in the indicated ARIPC cells. ( P-Q ) Indicated pathways significantly enriched in ACACA-depleted DU145 cells. Data are represented as mean ± SD in ( A , C-M ). * P < 0.05

    Journal: Cell Communication and Signaling : CCS

    Article Title: ACACA depletion activates the cPLA2–arachidonic acid–NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer

    doi: 10.1186/s12964-025-02363-0

    Figure Lengend Snippet: Depletion of ACACA causes increased arachidonic acid activity in prostate cancer cells. ( A ) Levels of two metabolites associated with arachidonic acid from metabolomic analysis data after ACACA knockdown in DU145 cells. ( B-M ) Heatmap and individual panels of arachidonic acid and its metabolite levels in ACACA-depleted PC3 cells. ( N-O ) Heatmaps showing the transcriptional expression levels of arachidonic acid pathway metabolic enzymes in the indicated ARIPC cells. ( P-Q ) Indicated pathways significantly enriched in ACACA-depleted DU145 cells. Data are represented as mean ± SD in ( A , C-M ). * P < 0.05

    Article Snippet: The human androgen receptor-independent prostate cancer (ARIPC) cell lines DU145 and PC3, the androgen receptor positive prostate cancer cell line LNCaP, the benign prostatic hyperplasia cell line BPH1, and HEK293T cells were obtained from the American Type Culture Collection (ATCC, Manassas, USA).

    Techniques: Activity Assay, Knockdown, Expressing

    cPLA2-driven arachidonic acid (AA) promotes inflammation and migration in ACACA-depleted ARIPC cells. ( A ) qPCR analysis of inflammation biomarker-related gene expression in ACACA-depleted DU145 cells after 72 h of treatment with 50 µM AA. ( B-E ) Evaluation of the migration potential of ACACA-depleted DU145 cells following AA treatment (72 h) at the indicated concentrations, via wound healing ( B ) and Transwell assays ( D ), with the quantification presented in ( C ) and ( E ), respectively. ( F ) Transcriptome data and ( G ) Western blot analysis of cPLA2 expression in ACACA-depleted DU145 cells. ( H ) Correlation analysis between cPLA2 and ACACA expression levels in the SU2C PolyA cohort. ( I ) Violin plots illustrating cPLA2 expression levels in mCRPC samples divided into high and low ACACA expression groups in the SU2C PolyA cohort. ( J ) qPCR analysis of cPLA2 expression after 72 h of treatment with silencing RNA in ACACA-depleted DU145 cells. ( K ) AA concentration measured by ELISA following cPLA2 silencing for 72 h in ACACA-depleted DU145 cells. ( L ) qPCR analysis of inflammation biomarker-related gene expression after cPLA2 silencing in ACACA-depleted DU145 cells. ( M-P ) Evaluation of the migration potential of ACACA-depleted ARIPC cells after cPLA2 silencing via wound healing ( M ) and Transwell ( O ) assays, with the quantification presented in ( N ) and ( P ), respectively. The data are presented as the means ± SDs in A, C, E, F, I, J-L, N , and P. * P < 0.05

    Journal: Cell Communication and Signaling : CCS

    Article Title: ACACA depletion activates the cPLA2–arachidonic acid–NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer

    doi: 10.1186/s12964-025-02363-0

    Figure Lengend Snippet: cPLA2-driven arachidonic acid (AA) promotes inflammation and migration in ACACA-depleted ARIPC cells. ( A ) qPCR analysis of inflammation biomarker-related gene expression in ACACA-depleted DU145 cells after 72 h of treatment with 50 µM AA. ( B-E ) Evaluation of the migration potential of ACACA-depleted DU145 cells following AA treatment (72 h) at the indicated concentrations, via wound healing ( B ) and Transwell assays ( D ), with the quantification presented in ( C ) and ( E ), respectively. ( F ) Transcriptome data and ( G ) Western blot analysis of cPLA2 expression in ACACA-depleted DU145 cells. ( H ) Correlation analysis between cPLA2 and ACACA expression levels in the SU2C PolyA cohort. ( I ) Violin plots illustrating cPLA2 expression levels in mCRPC samples divided into high and low ACACA expression groups in the SU2C PolyA cohort. ( J ) qPCR analysis of cPLA2 expression after 72 h of treatment with silencing RNA in ACACA-depleted DU145 cells. ( K ) AA concentration measured by ELISA following cPLA2 silencing for 72 h in ACACA-depleted DU145 cells. ( L ) qPCR analysis of inflammation biomarker-related gene expression after cPLA2 silencing in ACACA-depleted DU145 cells. ( M-P ) Evaluation of the migration potential of ACACA-depleted ARIPC cells after cPLA2 silencing via wound healing ( M ) and Transwell ( O ) assays, with the quantification presented in ( N ) and ( P ), respectively. The data are presented as the means ± SDs in A, C, E, F, I, J-L, N , and P. * P < 0.05

    Article Snippet: The human androgen receptor-independent prostate cancer (ARIPC) cell lines DU145 and PC3, the androgen receptor positive prostate cancer cell line LNCaP, the benign prostatic hyperplasia cell line BPH1, and HEK293T cells were obtained from the American Type Culture Collection (ATCC, Manassas, USA).

    Techniques: Migration, Biomarker Discovery, Gene Expression, Western Blot, Expressing, Concentration Assay, Enzyme-linked Immunosorbent Assay

    The NF-κB signaling pathway was enriched in ACACA-depleted ARIPC cells. ( A-B ) GSEA-derived significant pathways in KEGG signaling transduction identified from transcriptome data of ACACA-depleted ARIPC cells. ( C ) Venn diagram of KEGG signaling transduction pathways in ACACA-depleted DU145 and PC3 cells. The intersection indicates the number of shared pathways. ( D-E ) Heatmap of the expression of key genes associated with the intersecting pathways in ( C ). ( F ) Venn diagram illustrating the overlapping genes between the DU145 ( D ) and PC3 ( E ) cell lines. ( G-H ) NF-κB-related pathways significantly enriched in ACACA-depleted ARIPC cells. ( I ) UMAP plots of single-cell RNA sequencing (scRNA-seq) data from 6 metastatic prostate cancer patients after ARSI treatment ( GSE137829 ), with luminal epithelial cells highlighted by a black circle for subsequent analysis. ( J ) UMAP plots of luminal epithelial cells in ( I ) clustered into AR-positive and AR-negative subpopulations on the basis of the GSVA score. ( K ) UMAP plots of AR-negative cells in ( J ), which were further clustered into ACACA-high ( n = 91) and ACACA-low ( n = 285) subpopulations on the basis of mRNA expression. ( L ) GO enrichment analysis of DEGs between the ACACA-high and ACACA-low subpopulations in ( K ) revealed significant enrichment of the NF-κB and TNF signaling pathways

    Journal: Cell Communication and Signaling : CCS

    Article Title: ACACA depletion activates the cPLA2–arachidonic acid–NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer

    doi: 10.1186/s12964-025-02363-0

    Figure Lengend Snippet: The NF-κB signaling pathway was enriched in ACACA-depleted ARIPC cells. ( A-B ) GSEA-derived significant pathways in KEGG signaling transduction identified from transcriptome data of ACACA-depleted ARIPC cells. ( C ) Venn diagram of KEGG signaling transduction pathways in ACACA-depleted DU145 and PC3 cells. The intersection indicates the number of shared pathways. ( D-E ) Heatmap of the expression of key genes associated with the intersecting pathways in ( C ). ( F ) Venn diagram illustrating the overlapping genes between the DU145 ( D ) and PC3 ( E ) cell lines. ( G-H ) NF-κB-related pathways significantly enriched in ACACA-depleted ARIPC cells. ( I ) UMAP plots of single-cell RNA sequencing (scRNA-seq) data from 6 metastatic prostate cancer patients after ARSI treatment ( GSE137829 ), with luminal epithelial cells highlighted by a black circle for subsequent analysis. ( J ) UMAP plots of luminal epithelial cells in ( I ) clustered into AR-positive and AR-negative subpopulations on the basis of the GSVA score. ( K ) UMAP plots of AR-negative cells in ( J ), which were further clustered into ACACA-high ( n = 91) and ACACA-low ( n = 285) subpopulations on the basis of mRNA expression. ( L ) GO enrichment analysis of DEGs between the ACACA-high and ACACA-low subpopulations in ( K ) revealed significant enrichment of the NF-κB and TNF signaling pathways

    Article Snippet: The human androgen receptor-independent prostate cancer (ARIPC) cell lines DU145 and PC3, the androgen receptor positive prostate cancer cell line LNCaP, the benign prostatic hyperplasia cell line BPH1, and HEK293T cells were obtained from the American Type Culture Collection (ATCC, Manassas, USA).

    Techniques: Derivative Assay, Transduction, Expressing, RNA Sequencing, Protein-Protein interactions

    Inhibition of NF-κB suppresses inflammation and migration in ACACA-depleted ARIPC cells. ( A ) Western blot analysis of key proteins in the NF-κB signaling pathway and inflammatory signaling pathway after treatment with QNZ (10 nM, 72 h) in ACACA-depleted DU145 cells. ( B ) qPCR analysis of inflammation-related genes after treatment with QNZ (10 nM, 72 h) in ACACA-depleted DU145 cells. ( C-F ) Evaluation of the migration potential of ACACA-depleted ARIPC cells following treatment with QNZ (10 nM, 72 h) via wound healing ( C ) and Transwell ( E ) assays, with the quantification presented in ( D ) and ( F ), respectively. ( G ) qPCR analysis of Slug and Sanil in ACACA-depleted DU145 cells. ( H ) qPCR analysis of Slug and Sanil in the ACACA-depleted DU145 cells after treatment with QNZ (10 nM, 72 h). The data are presented as the means ± SD in ( B, D, F, G, H ). * P < 0.05

    Journal: Cell Communication and Signaling : CCS

    Article Title: ACACA depletion activates the cPLA2–arachidonic acid–NF-κB axis to drive inflammatory reprogramming in androgen receptor-independent prostate cancer

    doi: 10.1186/s12964-025-02363-0

    Figure Lengend Snippet: Inhibition of NF-κB suppresses inflammation and migration in ACACA-depleted ARIPC cells. ( A ) Western blot analysis of key proteins in the NF-κB signaling pathway and inflammatory signaling pathway after treatment with QNZ (10 nM, 72 h) in ACACA-depleted DU145 cells. ( B ) qPCR analysis of inflammation-related genes after treatment with QNZ (10 nM, 72 h) in ACACA-depleted DU145 cells. ( C-F ) Evaluation of the migration potential of ACACA-depleted ARIPC cells following treatment with QNZ (10 nM, 72 h) via wound healing ( C ) and Transwell ( E ) assays, with the quantification presented in ( D ) and ( F ), respectively. ( G ) qPCR analysis of Slug and Sanil in ACACA-depleted DU145 cells. ( H ) qPCR analysis of Slug and Sanil in the ACACA-depleted DU145 cells after treatment with QNZ (10 nM, 72 h). The data are presented as the means ± SD in ( B, D, F, G, H ). * P < 0.05

    Article Snippet: The human androgen receptor-independent prostate cancer (ARIPC) cell lines DU145 and PC3, the androgen receptor positive prostate cancer cell line LNCaP, the benign prostatic hyperplasia cell line BPH1, and HEK293T cells were obtained from the American Type Culture Collection (ATCC, Manassas, USA).

    Techniques: Inhibition, Migration, Western Blot

    A Schematic of the Tet-on LSH-shRNA system for regulating LSH expression in PC3 cells. Treatment with doxycycline for five days (DOX_5d) resulted in a significant reduction in LSH expression compared to cells that did not receive doxycycline treatment (DOX_0d). Following a five-day washout period, LSH expression was fully rescued to normal level (RESC). B Doxycycline- inducible knockdown of LSH was assessed using Western blotting to track alterations in protein levels, with endogenous β-ACTIN serving as the loading control. C-D Representative images and the percentage of cells with micronuclei ( C ) or DNA bridge ( D ) in Tet-on LSH-shRNA PC3 cells treated as described in panel A. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. E Representative images of γ-H2AX immunostaining and bar graph show the percentage of PC3 cells containing more than five γ-H2AX foci, treated as described in panel A. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. F Representative images of the alkaline comet assay and quantification of tail moment in PC3 cells, treated as described in panel A. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. G Representative images of Edu staining and quantification of nuclear Edu signal intensity in PC3 cells, treated as described in panel A. The scale bar represents 10 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. AU denotes arbitrary units. H-I Quantification of replication fork velocity ( H ) and fork asymmetry ( I ) is presented using Tukey-style box plots. Schematic diagram of the DNA fiber assay and representative images of stretched DNA fibers in PC3 cells treated as described in panel A. Cells were sequentially labeled at the indicated time points with two different thymidine analogues— CldU (red) and IdU (green). The scale bar represents 10 μm. The central line of a Tukey-style box plot indicates the median value, while the boxes and whiskers represent the 25th to 75th percentiles and the 5th to 95th percentiles, respectively. Outliers are displayed as individual points. Data are representative of n = 4 biologically independent experiments. ***p < 0.001; n.s. indicates not significant, as determined by the One-way ANOVA with Tukey’s multiple comparison test. J Scatter plots depicting the distances covered by right-moving and left-moving bi-directional replication forks following the CldU pulse in PC3 cells treated as described in panel H. The central areas, delineated by red lines, represent bi-directional forks with a length difference of less than 25%. The percentage of symmetric forks is also indicated. Data are representative of n = 4 biologically independent experiments. Source data are provided as a Source Data file.

    Journal: bioRxiv

    Article Title: LSH-mediated resolution of R-loops mitigates transcription-replication conflicts to preserve genomic stability in prostate cancer cells

    doi: 10.1101/2025.06.04.657812

    Figure Lengend Snippet: A Schematic of the Tet-on LSH-shRNA system for regulating LSH expression in PC3 cells. Treatment with doxycycline for five days (DOX_5d) resulted in a significant reduction in LSH expression compared to cells that did not receive doxycycline treatment (DOX_0d). Following a five-day washout period, LSH expression was fully rescued to normal level (RESC). B Doxycycline- inducible knockdown of LSH was assessed using Western blotting to track alterations in protein levels, with endogenous β-ACTIN serving as the loading control. C-D Representative images and the percentage of cells with micronuclei ( C ) or DNA bridge ( D ) in Tet-on LSH-shRNA PC3 cells treated as described in panel A. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. E Representative images of γ-H2AX immunostaining and bar graph show the percentage of PC3 cells containing more than five γ-H2AX foci, treated as described in panel A. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. F Representative images of the alkaline comet assay and quantification of tail moment in PC3 cells, treated as described in panel A. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. G Representative images of Edu staining and quantification of nuclear Edu signal intensity in PC3 cells, treated as described in panel A. The scale bar represents 10 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. AU denotes arbitrary units. H-I Quantification of replication fork velocity ( H ) and fork asymmetry ( I ) is presented using Tukey-style box plots. Schematic diagram of the DNA fiber assay and representative images of stretched DNA fibers in PC3 cells treated as described in panel A. Cells were sequentially labeled at the indicated time points with two different thymidine analogues— CldU (red) and IdU (green). The scale bar represents 10 μm. The central line of a Tukey-style box plot indicates the median value, while the boxes and whiskers represent the 25th to 75th percentiles and the 5th to 95th percentiles, respectively. Outliers are displayed as individual points. Data are representative of n = 4 biologically independent experiments. ***p < 0.001; n.s. indicates not significant, as determined by the One-way ANOVA with Tukey’s multiple comparison test. J Scatter plots depicting the distances covered by right-moving and left-moving bi-directional replication forks following the CldU pulse in PC3 cells treated as described in panel H. The central areas, delineated by red lines, represent bi-directional forks with a length difference of less than 25%. The percentage of symmetric forks is also indicated. Data are representative of n = 4 biologically independent experiments. Source data are provided as a Source Data file.

    Article Snippet: The cell lines utilized in this study included the androgen-independent prostate cancer cell line PC3 (ATCC), the androgen-dependent prostate cancer cell line LNCaP (ATCC), and the human embryonic kidney epithelial cell line HEK293T (ATCC).

    Techniques: shRNA, Expressing, Knockdown, Western Blot, Control, Two Tailed Test, MANN-WHITNEY, Immunostaining, Alkaline Single Cell Gel Electrophoresis, Staining, Labeling, Analogues, Comparison

    A Representative S9.6 immunostaining images showing R-loop levels in PC3 Tet-on LSH-shRNA cells under different conditions: untreated (Dox_0d), doxycycline-treated for five days (Dox_5d), and after a five-day doxycycline washout period (RESC). The scale bar represents 5 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. AU denotes arbitrary units. B Western blot analysis of PC3 Tet- on LSH-shRNA cells demonstrated the successful overexpression of both wild-type (WT) RNASEH1 and its WKKD/D210N mutant variants, all of which were tagged with V5. Detection was performed using an anti-V5 antibody, with β-Actin serving as the loading control. C Representative images of S9.6 immunostaining were utilized to assess R-loop levels in DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The scale bar represents 5 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. AU denotes arbitrary units. D Representative images of γ-H2AX immunostaining were obtained, alongside the percentage of cells exhibiting more than five γ-H2AX foci in DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. E Representative images of the alkaline comet assay, along with quantification of the tail moment, were obtained from DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. F Representative images of EdU staining and the quantification of nuclear EdU signal intensity were obtained from DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The scale bar represents 10 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 4 biologically independent experiments). *p < 0.05; ***p < 0.001, as determined by the two-tailed Mann–Whitney test. AU denotes arbitrary units. G-H Quantification of replication fork velocity ( G ) and fork asymmetry ( H ) is presented using Tukey-style box plots. Representative images depict stretched DNA fibers from DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The cells were sequentially labeled with CldU (red) and IdU (green). The scale bar represents 10 μm. The central line of a Tukey-style box plot indicates the median value, while the boxes and whiskers represent the 25th to 75th percentiles and the 5th to 95th percentiles, respectively. Outliers are displayed as individual points. Data are representative of n = 4 biologically independent experiments. *p < 0.05; ***p < 0.001; n.s. indicates not significant, as determined by the One- way ANOVA with Tukey’s multiple comparison test. I Scatter plots depicting the distances covered by right-moving and left-moving bi-directional replication forks following the CldU pulse in DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The central areas, delineated by red lines, represent bi-directional forks with a length difference of less than 25%. The percentage of symmetric forks is also indicated. Data are representative of n = 4 biologically independent experiments. J-K Representative images of FANCD2 ( J ) and BLM ( K ) immunostaining along with the percentage of cells exhibiting more than ten foci are presented for DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The scale bar represents 5 μm. Data are presented as a bar graph with mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. Source data are provided as a Source Data file.

    Journal: bioRxiv

    Article Title: LSH-mediated resolution of R-loops mitigates transcription-replication conflicts to preserve genomic stability in prostate cancer cells

    doi: 10.1101/2025.06.04.657812

    Figure Lengend Snippet: A Representative S9.6 immunostaining images showing R-loop levels in PC3 Tet-on LSH-shRNA cells under different conditions: untreated (Dox_0d), doxycycline-treated for five days (Dox_5d), and after a five-day doxycycline washout period (RESC). The scale bar represents 5 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. AU denotes arbitrary units. B Western blot analysis of PC3 Tet- on LSH-shRNA cells demonstrated the successful overexpression of both wild-type (WT) RNASEH1 and its WKKD/D210N mutant variants, all of which were tagged with V5. Detection was performed using an anti-V5 antibody, with β-Actin serving as the loading control. C Representative images of S9.6 immunostaining were utilized to assess R-loop levels in DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The scale bar represents 5 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. AU denotes arbitrary units. D Representative images of γ-H2AX immunostaining were obtained, alongside the percentage of cells exhibiting more than five γ-H2AX foci in DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The scale bar represents 5 μm. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. E Representative images of the alkaline comet assay, along with quantification of the tail moment, were obtained from DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. Data are presented as mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. F Representative images of EdU staining and the quantification of nuclear EdU signal intensity were obtained from DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The scale bar represents 10 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 4 biologically independent experiments). *p < 0.05; ***p < 0.001, as determined by the two-tailed Mann–Whitney test. AU denotes arbitrary units. G-H Quantification of replication fork velocity ( G ) and fork asymmetry ( H ) is presented using Tukey-style box plots. Representative images depict stretched DNA fibers from DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The cells were sequentially labeled with CldU (red) and IdU (green). The scale bar represents 10 μm. The central line of a Tukey-style box plot indicates the median value, while the boxes and whiskers represent the 25th to 75th percentiles and the 5th to 95th percentiles, respectively. Outliers are displayed as individual points. Data are representative of n = 4 biologically independent experiments. *p < 0.05; ***p < 0.001; n.s. indicates not significant, as determined by the One- way ANOVA with Tukey’s multiple comparison test. I Scatter plots depicting the distances covered by right-moving and left-moving bi-directional replication forks following the CldU pulse in DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The central areas, delineated by red lines, represent bi-directional forks with a length difference of less than 25%. The percentage of symmetric forks is also indicated. Data are representative of n = 4 biologically independent experiments. J-K Representative images of FANCD2 ( J ) and BLM ( K ) immunostaining along with the percentage of cells exhibiting more than ten foci are presented for DOX_0d and DOX_5d cells overexpressing either WT or WKKD RNASEH1. The scale bar represents 5 μm. Data are presented as a bar graph with mean ± s.d. (n = 4 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. Source data are provided as a Source Data file.

    Article Snippet: The cell lines utilized in this study included the androgen-independent prostate cancer cell line PC3 (ATCC), the androgen-dependent prostate cancer cell line LNCaP (ATCC), and the human embryonic kidney epithelial cell line HEK293T (ATCC).

    Techniques: Immunostaining, shRNA, Two Tailed Test, MANN-WHITNEY, Western Blot, Over Expression, Mutagenesis, Control, Alkaline Single Cell Gel Electrophoresis, Staining, Labeling, Comparison

    A Western blot analysis confirmed the knockout (KO) of LSH in PC3 cells and the overexpression of wild-type RNH1_V5 in LSH KO cells (KO+RNH1). LSH was detected with an anti-LSH antibody, RNH1_V5 was identified using an anti-V5 antibody, and β-Actin was used as the loading control. B The genomic distribution of R-loop CUT&Tag peaks is presented for LSH WT and KO cells. UTR refers to the untranslated region. The data are representative of n = 3 biologically independent experiments. C The differences in the genomic distribution of R-loop CUT&Tag peaks between LSH WT and KO cells are illustrated. UTR refers to the untranslated region. The data are representative of n = 3 biologically independent experiments. D Genome browser view of R-loop CUT&Tag data representing three independent biological replicates of LSH WT and KO cells. Samples treated with the RNH1 enzyme (RNH1) and KO+RNH1 cells were utilized as negative control groups. E The average R-loop CUT&Tag signals are shown over 6 kb regions centered on the transcription start site (TSS) in LSH WT and KO cells. Samples treated with the RNH1 enzyme (RNH1) and KO+RNH1 cells served as negative control groups to confirm the specificity of the detected R-loop signals. F The average R-loop CUT&Tag read density and heatmap for LSH WT and KO cells are presented within a 1 kb window around the center of peak regions. Samples treated with the RNH1 enzyme (RNH1) and KO+RNH1 cells were used as negative control groups to confirm the specificity of the detected R-loop signals. G The counts and fold changes of R-loop CUT&Tag peak gains (green) and losses (red) are presented for LSH KO cells compared to LSH WT cells. Additionally, the comparison between the WT group and the RNH1-treated group was carried out to confirm the specificity of the detected differential peaks. H Pathway analysis of genes exhibiting R-loop gains at the promoter region was conducted, comparing LSH KO and WT cells. The data are representative of n = 3 biologically independent experiments. Source data are provided as a Source Data file.

    Journal: bioRxiv

    Article Title: LSH-mediated resolution of R-loops mitigates transcription-replication conflicts to preserve genomic stability in prostate cancer cells

    doi: 10.1101/2025.06.04.657812

    Figure Lengend Snippet: A Western blot analysis confirmed the knockout (KO) of LSH in PC3 cells and the overexpression of wild-type RNH1_V5 in LSH KO cells (KO+RNH1). LSH was detected with an anti-LSH antibody, RNH1_V5 was identified using an anti-V5 antibody, and β-Actin was used as the loading control. B The genomic distribution of R-loop CUT&Tag peaks is presented for LSH WT and KO cells. UTR refers to the untranslated region. The data are representative of n = 3 biologically independent experiments. C The differences in the genomic distribution of R-loop CUT&Tag peaks between LSH WT and KO cells are illustrated. UTR refers to the untranslated region. The data are representative of n = 3 biologically independent experiments. D Genome browser view of R-loop CUT&Tag data representing three independent biological replicates of LSH WT and KO cells. Samples treated with the RNH1 enzyme (RNH1) and KO+RNH1 cells were utilized as negative control groups. E The average R-loop CUT&Tag signals are shown over 6 kb regions centered on the transcription start site (TSS) in LSH WT and KO cells. Samples treated with the RNH1 enzyme (RNH1) and KO+RNH1 cells served as negative control groups to confirm the specificity of the detected R-loop signals. F The average R-loop CUT&Tag read density and heatmap for LSH WT and KO cells are presented within a 1 kb window around the center of peak regions. Samples treated with the RNH1 enzyme (RNH1) and KO+RNH1 cells were used as negative control groups to confirm the specificity of the detected R-loop signals. G The counts and fold changes of R-loop CUT&Tag peak gains (green) and losses (red) are presented for LSH KO cells compared to LSH WT cells. Additionally, the comparison between the WT group and the RNH1-treated group was carried out to confirm the specificity of the detected differential peaks. H Pathway analysis of genes exhibiting R-loop gains at the promoter region was conducted, comparing LSH KO and WT cells. The data are representative of n = 3 biologically independent experiments. Source data are provided as a Source Data file.

    Article Snippet: The cell lines utilized in this study included the androgen-independent prostate cancer cell line PC3 (ATCC), the androgen-dependent prostate cancer cell line LNCaP (ATCC), and the human embryonic kidney epithelial cell line HEK293T (ATCC).

    Techniques: Western Blot, Knock-Out, Over Expression, Control, Negative Control, Comparison

    A Western blot analysis was conducted on PC3 Tet-on LSH-shRNA cells overexpressing either WT or D210N RNASEH1, both of which were tagged with V5. The cells were left untreated (DOX_0d) or treated with doxycycline for five days (DOX_5d). β-Actin was used as the loading control. B Representative images of S9.6/LSH proximity ligation assay (PLA) in DOX_0d and DOX_5d cells overexpressing either WT or D210N RNASEH1. PLA foci (red) indicate the association of the LSH antibody within a 40 nm distance of the S9.6 antibody. The scale bar represents 10 μm. The quantification of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ****p < 0.0001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. C Western blot analysis was performed to evaluate RNH1 or SETX knockdown in PC3 cells following siRNA transfection, with cells transfected with negative control (NC) siRNA serving as the control group. β-Actin was used as the loading control. D Representative images of S9.6/LSH PLA analysis in PC3 cells transfected with siRNA targeting RNH1 or SETX. The scale bar represents 10 μm. The quantification of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. E Western blot analysis of an RNA/DNA hybrid immunoprecipitation (IP) experiment was performed using the S9.6 antibody in PC3 cells overexpressing either WT or D210N RNASEH1. Both input and IP fractions were probed with LSH and lamin B1 antibodies, with LAMIN B1 serving as a negative control. Inputs are displayed on the left, and the S9.6-immunoprecipitated samples are shown on the right. The IgG Lane corresponds to a control IP using an IgG antibody. F Coomassie-stained SDS-PAGE gel of purified recombinant LSH_WT protein. G Electrophoretic mobility shift assay (EMSA) was conducted to analyze the binding of 0, 5, 10, and 20 μM of purified recombinant LSH_WT protein to 200 nM R-loops or RNA: DNA hybrids, both with and without 5’- RNA overhangs. The RNA 5’-terminus was labeled with 6-FAM fluorescence; DNA is depicted in black, while RNA is shown in red. The samples were loaded onto a 15% polyacrylamide gel and visualized using the Cy2 channel. H-J Representative immunofluorescence images depicting RAD51 ( H ), BRCA1 ( I ), and 53BP1 ( J ) foci in PC3 Tet-on LSH-shRNA cells treated with DMSO or with CPT (10 μM for 2 hours). The cells were left untreated (Dox_0d), treated with doxycycline for five days (Dox_5d), or subjected to a five-day doxycycline washout period (RESC). The scale bar represents 10 μm. The quantification of the number of RAD51, BRCA1, and 53BP1 foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ****p < 0.0001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. Source data are provided as a Source Data file.

    Journal: bioRxiv

    Article Title: LSH-mediated resolution of R-loops mitigates transcription-replication conflicts to preserve genomic stability in prostate cancer cells

    doi: 10.1101/2025.06.04.657812

    Figure Lengend Snippet: A Western blot analysis was conducted on PC3 Tet-on LSH-shRNA cells overexpressing either WT or D210N RNASEH1, both of which were tagged with V5. The cells were left untreated (DOX_0d) or treated with doxycycline for five days (DOX_5d). β-Actin was used as the loading control. B Representative images of S9.6/LSH proximity ligation assay (PLA) in DOX_0d and DOX_5d cells overexpressing either WT or D210N RNASEH1. PLA foci (red) indicate the association of the LSH antibody within a 40 nm distance of the S9.6 antibody. The scale bar represents 10 μm. The quantification of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ****p < 0.0001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. C Western blot analysis was performed to evaluate RNH1 or SETX knockdown in PC3 cells following siRNA transfection, with cells transfected with negative control (NC) siRNA serving as the control group. β-Actin was used as the loading control. D Representative images of S9.6/LSH PLA analysis in PC3 cells transfected with siRNA targeting RNH1 or SETX. The scale bar represents 10 μm. The quantification of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. E Western blot analysis of an RNA/DNA hybrid immunoprecipitation (IP) experiment was performed using the S9.6 antibody in PC3 cells overexpressing either WT or D210N RNASEH1. Both input and IP fractions were probed with LSH and lamin B1 antibodies, with LAMIN B1 serving as a negative control. Inputs are displayed on the left, and the S9.6-immunoprecipitated samples are shown on the right. The IgG Lane corresponds to a control IP using an IgG antibody. F Coomassie-stained SDS-PAGE gel of purified recombinant LSH_WT protein. G Electrophoretic mobility shift assay (EMSA) was conducted to analyze the binding of 0, 5, 10, and 20 μM of purified recombinant LSH_WT protein to 200 nM R-loops or RNA: DNA hybrids, both with and without 5’- RNA overhangs. The RNA 5’-terminus was labeled with 6-FAM fluorescence; DNA is depicted in black, while RNA is shown in red. The samples were loaded onto a 15% polyacrylamide gel and visualized using the Cy2 channel. H-J Representative immunofluorescence images depicting RAD51 ( H ), BRCA1 ( I ), and 53BP1 ( J ) foci in PC3 Tet-on LSH-shRNA cells treated with DMSO or with CPT (10 μM for 2 hours). The cells were left untreated (Dox_0d), treated with doxycycline for five days (Dox_5d), or subjected to a five-day doxycycline washout period (RESC). The scale bar represents 10 μm. The quantification of the number of RAD51, BRCA1, and 53BP1 foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ****p < 0.0001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. Source data are provided as a Source Data file.

    Article Snippet: The cell lines utilized in this study included the androgen-independent prostate cancer cell line PC3 (ATCC), the androgen-dependent prostate cancer cell line LNCaP (ATCC), and the human embryonic kidney epithelial cell line HEK293T (ATCC).

    Techniques: Western Blot, shRNA, Control, Proximity Ligation Assay, Two Tailed Test, MANN-WHITNEY, Knockdown, Transfection, Negative Control, Immunoprecipitation, Staining, SDS Page, Purification, Recombinant, Electrophoretic Mobility Shift Assay, Binding Assay, Labeling, Fluorescence, Immunofluorescence

    A Schematic representation of a human LSH mutation at the ATP binding site, illustrating a point mutation that replaces lysine (K) at amino acid 254 with alanine (A). B LSH 3’ UTR siRNA was designed to knock down endogenous LSH expression in PC3 cells (left panel), while these cells overexpressed either exogenous LSH(WT)-Flag or LSH(K254A)-Flag (middle panel). Following transient transfection with LSH 3’ UTR siRNA, western blot analysis (right panel) of PC3 cells indicated that the expression of exogenous LSH(WT)-Flag or LSH(K254A)-Flag protein was comparable to endogenous LSH expression, with β-Actin serving as the loading control. C Representative images of S9.6 immunostaining were used to evaluate the R-loop levels in PC3 cells treated as described in panel B. The scale bar represents 5 μm. Data are presented as a scatter plot with mean ± s.d. ( n = 3 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. D Coomassie-stained SDS-PAGE gel of purified recombinant LSH_WT and LSH_K254A proteins. E Electrophoretic mobility shift assays (EMSA) were conducted to analyze the binding of purified mutant LSH_K254A recombinant protein at concentrations of 0, 5, 10, and 20 μM to 200 nM R- loops or RNA: DNA hybrids, with or without 5’-RNA overhangs. The RNA 5’- terminus was labeled with 6-FAM fluorescence, with DNA represented in black and RNA in red. The samples were loaded onto a 15% polyacrylamide gel and visualized using the Cy2 channel. F Representative images of the alkaline comet assay along with quantification of tail moment in PC3 cells treated as outlined in panel B. Data are presented as a bar graph with mean ± s.d. ( n = 3 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. G Representative images of γ-H2AX immunostaining, complemented by a bar graph, illustrate the percentage of PC3 cells that contain more than five γ-H2AX foci, as treated in panel B. The scale bar represents 5 μm. Data are presented as a bar graph with mean ± s.d. ( n = 3 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. H Quantification of replication fork velocity and asymmetry in PC3 cells treated as described in panel B. The data are presented as a Tukey-style box plot, where the center line represents the median value, and the boxes and whiskers indicate the 25th to 75th percentiles and the 5th to 95th percentiles, respectively. Outliers are represented as individual points. The data are representative of n = 3 biologically independent experiments. ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. I DNA-RNA hybrids CUT&Tag-qPCR analysis at R-loop loci and repetitive sequences in PC3 cells treated as described in panel B. Signal values were normalized to the controls and plotted as mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; n.s. indicates not significant, as determined by the One-way ANOVA with Tukey’s multiple comparison test. J ChIP–qPCR analysis of γ-H2AX at R-loops loci and repetitive sequences in PC3 cells treated as described in panel B. Signal values were normalized to the controls and plotted as mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. Source data are provided as a Source Data file.

    Journal: bioRxiv

    Article Title: LSH-mediated resolution of R-loops mitigates transcription-replication conflicts to preserve genomic stability in prostate cancer cells

    doi: 10.1101/2025.06.04.657812

    Figure Lengend Snippet: A Schematic representation of a human LSH mutation at the ATP binding site, illustrating a point mutation that replaces lysine (K) at amino acid 254 with alanine (A). B LSH 3’ UTR siRNA was designed to knock down endogenous LSH expression in PC3 cells (left panel), while these cells overexpressed either exogenous LSH(WT)-Flag or LSH(K254A)-Flag (middle panel). Following transient transfection with LSH 3’ UTR siRNA, western blot analysis (right panel) of PC3 cells indicated that the expression of exogenous LSH(WT)-Flag or LSH(K254A)-Flag protein was comparable to endogenous LSH expression, with β-Actin serving as the loading control. C Representative images of S9.6 immunostaining were used to evaluate the R-loop levels in PC3 cells treated as described in panel B. The scale bar represents 5 μm. Data are presented as a scatter plot with mean ± s.d. ( n = 3 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. D Coomassie-stained SDS-PAGE gel of purified recombinant LSH_WT and LSH_K254A proteins. E Electrophoretic mobility shift assays (EMSA) were conducted to analyze the binding of purified mutant LSH_K254A recombinant protein at concentrations of 0, 5, 10, and 20 μM to 200 nM R- loops or RNA: DNA hybrids, with or without 5’-RNA overhangs. The RNA 5’- terminus was labeled with 6-FAM fluorescence, with DNA represented in black and RNA in red. The samples were loaded onto a 15% polyacrylamide gel and visualized using the Cy2 channel. F Representative images of the alkaline comet assay along with quantification of tail moment in PC3 cells treated as outlined in panel B. Data are presented as a bar graph with mean ± s.d. ( n = 3 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. G Representative images of γ-H2AX immunostaining, complemented by a bar graph, illustrate the percentage of PC3 cells that contain more than five γ-H2AX foci, as treated in panel B. The scale bar represents 5 μm. Data are presented as a bar graph with mean ± s.d. ( n = 3 biologically independent experiments). ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. H Quantification of replication fork velocity and asymmetry in PC3 cells treated as described in panel B. The data are presented as a Tukey-style box plot, where the center line represents the median value, and the boxes and whiskers indicate the 25th to 75th percentiles and the 5th to 95th percentiles, respectively. Outliers are represented as individual points. The data are representative of n = 3 biologically independent experiments. ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. I DNA-RNA hybrids CUT&Tag-qPCR analysis at R-loop loci and repetitive sequences in PC3 cells treated as described in panel B. Signal values were normalized to the controls and plotted as mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; n.s. indicates not significant, as determined by the One-way ANOVA with Tukey’s multiple comparison test. J ChIP–qPCR analysis of γ-H2AX at R-loops loci and repetitive sequences in PC3 cells treated as described in panel B. Signal values were normalized to the controls and plotted as mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. Source data are provided as a Source Data file.

    Article Snippet: The cell lines utilized in this study included the androgen-independent prostate cancer cell line PC3 (ATCC), the androgen-dependent prostate cancer cell line LNCaP (ATCC), and the human embryonic kidney epithelial cell line HEK293T (ATCC).

    Techniques: Mutagenesis, Binding Assay, Knockdown, Expressing, Transfection, Western Blot, Control, Immunostaining, Two Tailed Test, MANN-WHITNEY, Staining, SDS Page, Purification, Recombinant, Electrophoretic Mobility Shift Assay, Labeling, Fluorescence, Alkaline Single Cell Gel Electrophoresis, Comparison, ChIP-qPCR

    LSH interacts with FANCD2 to resolve transcription- replication conflicts mediated by R-loops at stalled replication forks. A Representative images of S9.6 immunostaining to evaluate R-loop levels in PC3 Tet-on LSH-shRNA cells following transient transfection with siRNAs targeting UAP56, THOC1, FANCD2, or SETX. The cells were left untreated (DOX_0d) or treated with doxycycline for five days (DOX_5d). The scale bar represents 5 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ** p < 0.01; ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. AU denotes arbitrary units. B Representative images of PCNA/RNAPIIS2P PLA in cells treated as described in panel A. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ** p < 0.01; ****p < 0.0001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. C Western blot analysis was performed in PC3 Tet-on LSH-shRNA cells overexpressing either wild-type (WT) or WKKD RNASEH1, following transient transfection with siRNAs targeting UAP56 or SETX. GAPDH was used as the loading control. D Representative images of LSH/FANCD2 PLA in cells treated as described in panel C. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ***p < 0.001; ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. E Representative images of LSH/PCNA PLA in PC3 Tet-on LSH-shRNA cells, which were left untreated (DOX_0d) or treated with doxycycline for five days (DOX_5d). Negative controls, utilizing only LSH or PCNA antibodies, were performed to verify the specificity of the detected PLA signals. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. F Representative images of LSH/γH2AX PLA in cells treated as described in panel C. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). *p < 0.05; ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. G Representative images of LSH/γ-RPA32 S4/S8P PLA in cells treated as described in panel C. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ***p < 0.001; ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. Source data are provided as a Source Data file.

    Journal: bioRxiv

    Article Title: LSH-mediated resolution of R-loops mitigates transcription-replication conflicts to preserve genomic stability in prostate cancer cells

    doi: 10.1101/2025.06.04.657812

    Figure Lengend Snippet: LSH interacts with FANCD2 to resolve transcription- replication conflicts mediated by R-loops at stalled replication forks. A Representative images of S9.6 immunostaining to evaluate R-loop levels in PC3 Tet-on LSH-shRNA cells following transient transfection with siRNAs targeting UAP56, THOC1, FANCD2, or SETX. The cells were left untreated (DOX_0d) or treated with doxycycline for five days (DOX_5d). The scale bar represents 5 μm. Signal intensity data are depicted as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ** p < 0.01; ***p < 0.001; n.s. indicates not significant, as determined by the two-tailed Mann– Whitney test. AU denotes arbitrary units. B Representative images of PCNA/RNAPIIS2P PLA in cells treated as described in panel A. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ** p < 0.01; ****p < 0.0001; n.s. indicates not significant, as determined by the two-tailed Mann–Whitney test. C Western blot analysis was performed in PC3 Tet-on LSH-shRNA cells overexpressing either wild-type (WT) or WKKD RNASEH1, following transient transfection with siRNAs targeting UAP56 or SETX. GAPDH was used as the loading control. D Representative images of LSH/FANCD2 PLA in cells treated as described in panel C. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ***p < 0.001; ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. E Representative images of LSH/PCNA PLA in PC3 Tet-on LSH-shRNA cells, which were left untreated (DOX_0d) or treated with doxycycline for five days (DOX_5d). Negative controls, utilizing only LSH or PCNA antibodies, were performed to verify the specificity of the detected PLA signals. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. F Representative images of LSH/γH2AX PLA in cells treated as described in panel C. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). *p < 0.05; ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. G Representative images of LSH/γ-RPA32 S4/S8P PLA in cells treated as described in panel C. The scale bar represents 5 μm. Quantification of the number of PLA foci per nucleus for each experimental condition is presented as a scatter plot with mean ± s.d. (n = 3 biologically independent experiments). ***p < 0.001; ****p < 0.0001, as determined by the two-tailed Mann–Whitney test. Source data are provided as a Source Data file.

    Article Snippet: The cell lines utilized in this study included the androgen-independent prostate cancer cell line PC3 (ATCC), the androgen-dependent prostate cancer cell line LNCaP (ATCC), and the human embryonic kidney epithelial cell line HEK293T (ATCC).

    Techniques: Immunostaining, shRNA, Transfection, Two Tailed Test, MANN-WHITNEY, Western Blot, Control

    A The Venn diagram illustrates the number of overlapping genes (n = 471) that are downregulated in LSH KO cells (KO vs. WT, red) and restored in KO+RNH1 cells (blue). Data are representative of n = 3 biologically independent experiments. B Pathway analysis of the overlapping genes was conducted, with a primary focus on cancer signaling pathways, transcriptional activity, and cellular biological processes. Data are representative of n = 3 biologically independent experiments. C Heat map displaying the relative expression levels of overlapping genes in WT, KO, and KO+RNH1 PC3 cells, as outlined in the pathway analysis from panel B. Data are representative of n = 3 biologically independent experiments. D The average R-loop CUT&Tag signals over 6 kb regions centered on the TSS of overlapping genes were analyzed in WT, KO, and KO+RNH1 PC3 cells. Samples treated with the RNH1 enzyme served as a negative control to confirm the specificity of the detected R-loop signals. Data are representative of n = 3 biologically independent experiments. TSS denotes transcription start site. E Co-IP experiments were performed in PC3 cells to evaluate the interaction between LSH and MYC as well as E2F3 proteins. Whole-cell lysates were collected and subjected to immunoprecipitation using either an anti-LSH antibody or an IgG control. Immunoblotting was subsequently carried out with anti-MYC and anti-E2F3 antibodies. Input samples are indicated, and the data represent n = 3 biologically independent experiments. F Enrichment plots for MYC and E2F targets were generated to compare WT and KO cells and further validated by the comparison of KO cells with KO+RNH1 cells. Data are representative of n = 3 biologically independent experiments. G The heat map illustrates the relative expression levels of five selected MYC and E2F target genes among the overlapping genes in WT, KO, and KO+RNH1 PC3 cells. Data are representative of n = 3 biologically independent experiments. H Genome browser snapshots of CUT&Tag-seq data depict R-loop accumulation at the selected MYC target genes, as illustrated in panel G, for WT, KO, and KO+RNH1 PC3 cells. I ChIP–qPCR analysis of γ-H2AX at the selected MYC target genes, as illustrated in panel G, for WT, KO, and KO+RNH1 PC3 cells. Values were normalized to the WT group and presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; ****p < 0.0001, as determined by the One-way ANOVA with Tukey’s multiple comparison test. J ChIP–qPCR analysis of FANCD2 at the selected MYC target genes, as shown in panel G, for WT and KO PC3 cells. Data are presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). *p < 0.05; **p < 0.01; ***p < 0.001, as determined by the two- tailed Mann–Whitney test. K ChIP–qPCR analysis of RNAPIIS2P at the promoter and gene body regions of the selected MYC target genes, as shown in panel G, for WT, KO, and KO+RNH1 PC3 cells. Values were normalized to the WT group and presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; ****p < 0.0001, as determined by the One-way ANOVA with Tukey’s multiple comparison test. L Genome browser snapshots of CUT&Tag-seq data depict R-loop accumulation at the selected E2F target genes, as illustrated in panel G, for WT, KO, and KO+RNH1 PC3 cells. M ChIP–qPCR analysis of γ-H2AX at the selected E2F target genes, as illustrated in panel G, for WT, KO, and KO+RNH1 PC3 cells. Values were normalized to the WT group and presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; ****p < 0.0001, as determined by the One-way ANOVA with Tukey’s multiple comparison test. N ChIP–qPCR analysis of FANCD2 at the selected E2F target genes, as shown in panel G, for WT and KO PC3 cells. Data are presented as a bar graph with mean ±s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001, as determined by the two-tailed Mann–Whitney test. O ChIP–qPCR analysis of RNAPIIS2P at the promoter and gene body regions of the selected E2F target genes, as shown in panel G, for WT, KO, and KO+RNH1 PC3 cells. Values were normalized to the WT group and presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, as determined by the One-way ANOVA with Tukey’s multiple comparison test. Source data are provided as a Source Data file.

    Journal: bioRxiv

    Article Title: LSH-mediated resolution of R-loops mitigates transcription-replication conflicts to preserve genomic stability in prostate cancer cells

    doi: 10.1101/2025.06.04.657812

    Figure Lengend Snippet: A The Venn diagram illustrates the number of overlapping genes (n = 471) that are downregulated in LSH KO cells (KO vs. WT, red) and restored in KO+RNH1 cells (blue). Data are representative of n = 3 biologically independent experiments. B Pathway analysis of the overlapping genes was conducted, with a primary focus on cancer signaling pathways, transcriptional activity, and cellular biological processes. Data are representative of n = 3 biologically independent experiments. C Heat map displaying the relative expression levels of overlapping genes in WT, KO, and KO+RNH1 PC3 cells, as outlined in the pathway analysis from panel B. Data are representative of n = 3 biologically independent experiments. D The average R-loop CUT&Tag signals over 6 kb regions centered on the TSS of overlapping genes were analyzed in WT, KO, and KO+RNH1 PC3 cells. Samples treated with the RNH1 enzyme served as a negative control to confirm the specificity of the detected R-loop signals. Data are representative of n = 3 biologically independent experiments. TSS denotes transcription start site. E Co-IP experiments were performed in PC3 cells to evaluate the interaction between LSH and MYC as well as E2F3 proteins. Whole-cell lysates were collected and subjected to immunoprecipitation using either an anti-LSH antibody or an IgG control. Immunoblotting was subsequently carried out with anti-MYC and anti-E2F3 antibodies. Input samples are indicated, and the data represent n = 3 biologically independent experiments. F Enrichment plots for MYC and E2F targets were generated to compare WT and KO cells and further validated by the comparison of KO cells with KO+RNH1 cells. Data are representative of n = 3 biologically independent experiments. G The heat map illustrates the relative expression levels of five selected MYC and E2F target genes among the overlapping genes in WT, KO, and KO+RNH1 PC3 cells. Data are representative of n = 3 biologically independent experiments. H Genome browser snapshots of CUT&Tag-seq data depict R-loop accumulation at the selected MYC target genes, as illustrated in panel G, for WT, KO, and KO+RNH1 PC3 cells. I ChIP–qPCR analysis of γ-H2AX at the selected MYC target genes, as illustrated in panel G, for WT, KO, and KO+RNH1 PC3 cells. Values were normalized to the WT group and presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; ****p < 0.0001, as determined by the One-way ANOVA with Tukey’s multiple comparison test. J ChIP–qPCR analysis of FANCD2 at the selected MYC target genes, as shown in panel G, for WT and KO PC3 cells. Data are presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). *p < 0.05; **p < 0.01; ***p < 0.001, as determined by the two- tailed Mann–Whitney test. K ChIP–qPCR analysis of RNAPIIS2P at the promoter and gene body regions of the selected MYC target genes, as shown in panel G, for WT, KO, and KO+RNH1 PC3 cells. Values were normalized to the WT group and presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; ****p < 0.0001, as determined by the One-way ANOVA with Tukey’s multiple comparison test. L Genome browser snapshots of CUT&Tag-seq data depict R-loop accumulation at the selected E2F target genes, as illustrated in panel G, for WT, KO, and KO+RNH1 PC3 cells. M ChIP–qPCR analysis of γ-H2AX at the selected E2F target genes, as illustrated in panel G, for WT, KO, and KO+RNH1 PC3 cells. Values were normalized to the WT group and presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001; ****p < 0.0001, as determined by the One-way ANOVA with Tukey’s multiple comparison test. N ChIP–qPCR analysis of FANCD2 at the selected E2F target genes, as shown in panel G, for WT and KO PC3 cells. Data are presented as a bar graph with mean ±s.d. (n = 3 biologically independent experiments). **p < 0.01; ***p < 0.001, as determined by the two-tailed Mann–Whitney test. O ChIP–qPCR analysis of RNAPIIS2P at the promoter and gene body regions of the selected E2F target genes, as shown in panel G, for WT, KO, and KO+RNH1 PC3 cells. Values were normalized to the WT group and presented as a bar graph with mean ± s.d. (n = 3 biologically independent experiments). *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, as determined by the One-way ANOVA with Tukey’s multiple comparison test. Source data are provided as a Source Data file.

    Article Snippet: The cell lines utilized in this study included the androgen-independent prostate cancer cell line PC3 (ATCC), the androgen-dependent prostate cancer cell line LNCaP (ATCC), and the human embryonic kidney epithelial cell line HEK293T (ATCC).

    Techniques: Protein-Protein interactions, Activity Assay, Expressing, Negative Control, Co-Immunoprecipitation Assay, Immunoprecipitation, Control, Western Blot, Generated, Comparison, ChIP-qPCR, Two Tailed Test, MANN-WHITNEY